Artificial Intelligence in hepatology: A position paper by the Italian Association for the Study of the Liver

Comprehensive Summary

Balsano et al. outline the expanding role of artificial intelligence across hepatology. They emphasize its potential for both clinical and research applications. This paper describes how artificial intelligence tools, specifically machine learning and deep learning, can be utilized to improve early diagnosis, disease staging, and prognosis in liver disease, such as fatty liver disease, viral hepatitis, cirrhosis, and hepatocellular carcinoma. Balsano et al. highlight the ability of artificial intelligence to integrate complex data sets such as imaging, histology, and health records to enhance precision medicine.

Outcomes and Implications

Integration into clinical practice requires careful and intentional implementation. Clinicians will need to develop an understanding of the artificial intelligence tools used to aid in assessing liver prognosis. Standardized methods, collaboration, and regulatory frameworks are all needed before implementing these tools in clinical practice. Healthcare systems need to prioritize diverse datasets and enforce standards of validation to prevent bias in these tools. If used responsibly, artificial intelligence technologies can allow for more personalized and proactive treatment plans. Failure in responsible use can cause ethics violations, such as reinforcing existing disparities, as well as undermining trust in medical decision-making. Artificial intelligence can play a significant role in aiding the treatment of liver disease, but it needs to be integrated in a methodical manner.